[March 03, 2015]

Research and Markets: Warts Pipeline Review 2015 - 12 Companies & 14 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/2qwjmh/warts_pipeline) has announced the addition of the "Warts - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Warts, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Warts and special features on latestage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

• 3M (News - Alert) Drug Delivery Systems
• Agilvax, Inc.
• Anaconda Pharma
• BioMAS Ltd.
• Burke Pharmaceuticals, LLC
• Cutanea Life Sciences
• Foamix Pharmaceuticals Ltd.
• G&E Herbal Biotechnology Co., Ltd.
• Helix BioPharma Corp.
• NanoViricides, Inc.
• Nielsen Biosciences, Inc.
• ViroStatics, srl

Drug Profiles

• (digoxin + furosemide)
• 854-A
• A-101
• AP-611074
• AS-101
• AX-03
• BURKE-201
• Candida Albicans Antigen
• HerpeCide-I
• imiquimod
• interferon alpha-2b (recombinant)
• PP-210
• Small Molecule to Inhibit CDK9 for HPV Associated Cancers and Warts
• SRT-100

For more information visit http://www.researchandmarkets.com/research/2qwjmh/warts_pipeline

[ Back To TMCnet.com's Homepage ]